The effect of varenicline for smoking cassection

Abstract

The purpose of this research is need to know the effect of the drug varenicline to stop smoking both those who are not sick and those who are chronically ill, to develop appropriate models of smoking cessation services. It is retrospective descriptive research. Population used in the research include: Patients wishing to stop smoking and want to take medicine. It has been assessed that a condition of nicotine addiction heavy stick together for at least one item as follows: It had a history of stop smoking within one year but was unsuccessful, It has been diagnosed with disease emphysema, it have been diagnosed with coronary heart disease, it has been diagnosed with other chronic non-communicable diseases such as: Diabetes, Hypertension cancer and are willing to be monitored continuously. The research tool is to provide varenicline medication. Follow up the next appointment 2 weeks, 1, 2, 3 months or whenever a diagnosis of NCD. Data were collected by questionnaire. The results reaffirm stop smoking from the carbon monoxide in the breath. (End-expiratory carbon monoxide) levels <10 ppm.

The results of the drug varenicline on stop smoking. There were 61 participants, most of who were between the ages of 41-50 years old at 29.50 percent, secondary to those aged 51-60 years at 26.22 percent. The lowest age was 21 years, the highest age was 88 years, the average age was 48 years, and 98.36 percent was male. Most of them had the right to universal health coverage at 68.85 percent, secondary to social security at 19.67 percent. Most of the reasons to stop using drugs those who have stop smoking but had no success at 54.09 percent, secondary to diagnosed with NCD 40.98 percent..Number of cigarettes per day, mostly 20 cigarettes or more at 47.54 percent, secondary to 11-19 cigarettes per day (moderate) at 36.06 percent. Duration of smoking the first cigarette after waking up mostly less than 30 minutes after waking up 70.49 percent, , secondary to more than 30 minutes but less than 1 hours after waking up 24.59 percent. The track samples one month, mostly smokers are 24 people at 39.34 percent, by reducing the amount / number of cigarettes to 22 people, 36.06 percent. Trace the number of smokers per day 1-10 cigarettes per day (less) 52.45 percent, increase than before the start of the drug, secondary to amount of 11-19 cigarettes per day (moderate) at 32.78 percent. Duration of first cigarette smoking after wake up is less than 30 minutes after waking up18.03 percent, decreased than before began to using drugs. But duration of first cigarette smoking after waking up 1 hour or more after waking up 22.95 percent, increased volume.The follow-up period of 3 months. Mostly the reduction in volume / number of cigarettes was 44.26 percent, secondary to no smoking, then 34.42 percent .The increase proportion was mainly from 1-10 cigarettes per day (less) 36.06 percent Duration of first cigarette smoking 1 hour or more after waking 36.06 percent, secondary to non-smoking 34.42%. Carbon monoxide levels in mostly breaths <10 ppm is considered non-smoking at 83.60 percent. This study confirms that varenicline has a beneficial effect on stop smoking.

Suggestion However, there should be further study; in addition, there should be further studies to further evaluate the worthiness of Varenicline.